76470 Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices 

monitoring, program evaluation, and 

technical assistance. The monitoring 

and evaluation plan for the HDSP 

program is part of an overall initiative 

within CDC’s National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP) to promote more 

efficient ways of using resources and 

achieving greater health impact. CDC 

plans to increase the number of HDSP 

awardees reporting through the MIS 

from 33 to 42. 

CDC will discontinue approval to use 

the DHDSP MIS for collecting 

information from WISEWOMAN 

program awardees. The WISEWOMAN 

program is a demonstration program 

that extends cardiovascular diseaserelated services to a subset of women 

who also receive services through the 

National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP). 

Although approval was obtained to use 

the DHDSP MIS for collecting progress 

and activity information from 

WISEWOMAN awardees, the 

information collection was not 

implemented due to a change in plans 

for monitoring these awardees. The 

current WISEWOMAN data collection is 

described in OMB No. 0920–0612 

(WISEWOMAN Reporting System, exp. 

3/31/2013). 

CDC will continue to use the 

information collected through the 

DHDSP MIS to identify state-specific 

heart disease and stroke prevention 

priorities and objectives, and to describe 

the impact and reach of program 

interventions. Respondents will be 42 

health departments in 41 States and the 

District of Columbia (DC). Respondents 

will continue to submit their progress 

and activity information to CDC semiannually. The estimated burden per 

response is six hours. There are no costs 

to respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

State-Based HDSP Programs ......................................................................... 42 2 6 504 

Dated: December 2, 2010. 

Carol Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–30764 Filed 12–7–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–11–0770] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Carol Walker, Acting CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS–D74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

National HIV Behavioral Surveillance 

System (NHBS) (OMB no. 0920–0770, 

exp. 03/31/2011)—Extension—National 

Center for HIV, Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The purpose of this data collection is 

to monitor behaviors related to Human 

Immunodeficiency Virus (HIV) infection 

among persons at high risk for infection 

in the United States. The primary 

objectives of the NHBS system are to 

obtain data from samples of persons at 

risk to: (a) Describe the prevalence and 

trends in risk behaviors; (b) describe the 

prevalence of and trends in HIV testing 

and HIV infection; (c) describe the 

prevalence of and trends in use of HIV 

prevention services; (d) identify met and 

unmet needs for HIV prevention 

services in order to inform health 

departments, community based 

organizations, community planning 

groups and other stakeholders. 

This project addresses the goals of the 

National HIV/AIDS Strategy for the 

United States, which calls for State and 

local health departments to monitor 

progress towards the national goal of 

reducing new HIV infections by 25% by 

2015. NHBS contributes to this national 

goal by describing and monitoring the 

HIV risk behaviors, HIV seroprevalence 

and incidence, and HIV prevention 

experiences of persons at highest risk 

for HIV infection. 

The Centers for Disease Control and 

Prevention request approval for a 3-year 

extension for the previously approved 

National HIV Behavioral Surveillance 

System (NHBS), OMB number 0920– 

0770, which expires 03/31/2011. Data 

are collected through anonymous, inperson interviews conducted with 

persons systematically selected from 25 

Metropolitan Statistical Areas (MSAs) 

throughout the United States; these 25 

MSAs were chosen based on having 

high AIDS prevalence. Persons at risk 

for HIV infection to be interviewed for 

NHBS include men who have sex with 

men (MSM), injecting drug users (IDU), 

and heterosexuals at increased risk of 

HIV (HET). A brief screening interview 

will be used to determine eligibility for 

participation in the behavioral 

assessment. 

The data from the behavioral 

assessment will provide frequency 

estimates of behavior related to the risk 

of HIV and other sexually transmitted 

diseases, prior testing for HIV, and use 

of HIV prevention services. All persons 

interviewed will also be offered an HIV 

test, and will participate in a pre-test 

counseling session. No other Federal 

agency systematically collects this type 

of information from persons at risk for 

HIV infection. These data will have a 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices 76471 

substantial impact on prevention 

program development and monitoring at 

the local, State, and national levels. 

CDC estimates that NHBS will 

involve, per year in each of the 25 

MSAs, eligibility screening of 50 to 200 

persons and eligibility screening plus 

the behavioral assessment with 500 

eligible respondents, resulting in a total 

of 37,500 eligible survey respondents 

and 7,500 ineligible screened persons 

during a 3-year period. Data collection 

will rotate such that interviews will be 

conducted among one group per year: 

MSM in year 1, IDU in year 2, and HET 

in year 3. The type of data collected for 

each group will vary slightly due to 

different sampling methods and risk 

characteristics of the group. 

Participation of respondents is 

voluntary and there is no cost to the 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(hours) 

Total burden 

(in hours) 

Year 1: 

Men Approached at Eligible 

Venue.

Screener ........................................... 17,500 1 5/60 1,458 

Eligible Men ............................... Behavioral Assessment .................... 12,500 1 60/60 12,500 

Year 2: 

Injecting Drug Users Referred 

by Peer Recruiters.

Screener ........................................... 13,750 1 5/60 1,146 

Eligible Injecting Drug Users ..... Behavioral Assessment .................... 12,500 1 85/60 17,708 

Year 3: 

Heterosexual Men and Women 

Referred by Peer Recruiters.

Screener ........................................... 13,750 1 5/60 1,146 

Eligible Heterosexual Men and 

Women.

Behavioral Assessment .................... 12,500 1 70/60 14,583 

Total .................................... ........................................................... 45,000 1 ........................ 48,541 

Dated: December 2, 2010. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–30763 Filed 12–7–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3234–N] 

Medicare Program; Renewal of the 

Medicare Evidence Development & 

Coverage Advisory Committee 

(MEDCAC) 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

renewal of the Medicare Evidence 

Development & Coverage Advisory 

Committee (MEDCAC). 

ADDRESSES: Copies of the Charter: To 

obtain a copy of the Secretary’s Charter 

for the MEDCAC submit a request to: 

See FOR FURTHER INFORMATION CONTACT. 

FOR FURTHER INFORMATION CONTACT: 

Maria Ellis, Executive Secretary for 

MEDCAC, Centers for Medicare & 

Medicaid Services, Office of Clinical 

Standards and Quality, Coverage and 

Analysis Group, C1–09–06, 7500 

Security Boulevard, Baltimore, MD 

21244 or contact Ms. Ellis by phone 

(410–786–0309) or via e-mail at 

Maria.Ellis@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

On December 14, 1998, we published 

a notice in the Federal Register (63 FR 

68780) announcing the establishment of 

the Medicare Coverage Advisory 

Committee (MCAC). The Secretary 

signed the initial charter for the MCAC 

on November 24, 1998. The MCAC was 

originally established to provide 

independent guidance and expert 

advice to CMS on specific clinical 

topics. In 2007 the Charter was renewed 

and the name MCAC was modified to 

Medicare Evidence Development and 

Coverage Advisory Committee 

(MEDCAC) to more accurately reflect 

the Committee’s role. The MEDCAC is 

advisory, with the final decision on all 

issues resting with CMS. Under the 

current charter, the MEDCAC advises 

the Secretary of the Department of 

Health and Human Services (DHHS) and 

the Administrator of the CMS, on the 

quality of evidence on clinical topics 

under review by CMS. 

The MEDCAC consists of a pool of 

100 appointed members. Members are 

selected from authorities in clinical 

medicine of all specialties, 

administrative medicine, public health, 

biologic and physical sciences, health 

care data and information management 

and analysis, patient advocacy, the 

economics of health care, medical ethics 

and other related professions such as 

epidemiology and biostatistics, and 

methodology of trial design. There are 

94 at-large standing voting members. Six 

of the members are patient advocates 

and six are nonvoting members 

representing the industry interest. 

II. Provisions of this Notice 

This notice announces the signing of 

the MEDCAC charter renewal by the 

Secretary on November 23, 2010. The 

new charter makes the following 

changes: 

• There are 4–8 meetings per year. 

• A period of service for the Chair 

and Vice-Chair of no more than 4 years. 

The MEDCAC functions on a 

committee basis. The MEDCAC—(1) 

Hears public testimony; (2) reviews 

medical literature, technology 

assessments and other relevant evidence 

and advises CMS on the strength and 

weaknesses of that evidence; (3) advises 

CMS of any evidence gaps that may 

exist and recommends the types of 

evidence that should be developed to 

fill those evidentiary gaps. The 

Committee may be asked to develop 

recommendations about specific clinical 

issues under review and to review and 

comment upon proposed or existing 

Medicare coverage policies. The 

Committee may also be asked to 

comment on pertinent aspects of 


jlentini on DSKJ8SOYB1PROD with NOTICES